Dr. Atiq is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 773-702-1000
Education & Training
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 2014 - 2017- University of Arkansas For Medical Sciences College of MedicineClass of 2014
Certifications & Licensure
AR State Medical License 2017 - 2026
IL State Medical License 2023 - 2026
DC State Medical License 2020 - 2024
NY State Medical License 2017 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 85 citationsA Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).Ying Z. Mazzu, Joshua Armenia, Goutam Chakraborty, Yuki Yoshikawa, Si'Ana A. Coggins
Clinical Cancer Research. 2019-07-15 - 10 citationsAttenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2-altered Prostate TumorsGoutam Chakraborty, Nabeela Khan Patail, Rahim Hirani, Subhiksha Nandakumar, Ying Z. Mazzu
Clinical Cancer Research. 2021-03-15 - 20 citationsRibonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.Ying Z. Mazzu, Joshua Armenia, Subhiksha Nandakumar, Goutam Chakraborty, Yuki Yoshikawa
Molecular Oncology. 2020-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
